PharmaVOICE - 
January 2004
Purchase Issue

In Every Issue
What’s New
What’s new New healthcare-related products, services, and companies The HBA [...]
By
PharmaOutlet
Contributed by Paul Harris Creating Memorable Visual Branding This past [...]
By
For Art’s Sake
What can you say about a nearly 12-year-old brand that [...]
By
PharmaTrax
Pharma Trax Sales, Marketing, And R&D Trends Affecting the Healthcare [...]
By
Talent Pool
talent pool executive appointments and promotions in the healthcare industry [...]
By
E-Media
E-Media New electronic and web-based applications, sites, and technologies Health [...]
By
What’s on Your Mind — Opinions
What’s on your mind opinions Year in Review Continuing regulatory [...]
By
Letter From the Editor
Letter From The Editor More than 40% of executives recently [...]
By

Taren Grom, Editor

Raise Your Voice — Letters
Raise your Voice Letters Medicare Drug Benefit – A Terrible [...]
By

On The Cover

Prioritizing the Pipeline: The Critical Role of Porfolio Management
Prioritizing the Pipeline The critical role of portfolio management Increased pressures on the pharmaceutical industry – shrinking pipelines, rising costs, reimbursement issues, regulatory pressures, and consumer demands – mean companies have to find ways to focus on the projects that will meet corporate goals. An optimal way to do that is through portfolio management. Portfolio [...]
By

Kim Ribbink

Features

Data Strategy: Cracking the Marketing Code
Data Strategy Cracking the Marketing Code The creation of relevant marketing messages often relies on data that have been appropriately aggregated and analyzed. A well-conceived and implemented data strategy provides for a more targeted approach that ensures better results and increases return on investment. Pharmaceutical sales in the United States are projected to grow at [...]
By
Pharmacogenomics: The Next Step Forward
Pharmacogenomics The Next Step Forward The first NDA based on pharmacogenomic data may still be a long time coming, but in anticipation of such filings, the FDA has issued a draft guidance that encourages companies to conduct pharmacogenomic tests during the drug-development process. Pharmacogenomics will facilitate drug discovery and allow pharmaceutical companies to produce therapies [...]
By

Denise Myshko

Diagnostics and Devices: A Different Arena
Diagnostics and Devices different arena By Elisabeth Pena With smaller marketing budgets and a more focused, cost-conscious audience, the device and diagnostic sectors face challenges that require different strategies from their pharmaceutical counterparts. A number of world events bode well for the future of medical devices. According to Kalorama Information, a division of MarketResearch.com, an [...]
By

Elisabeth Pena

Dorothy Smith: Education, the Best Medicine
education, the best medicine Dr. Dorothy Smith has devoted her career to consumer healthcare education. She began by shaking up the role of the pharmacist by pushing for patient-counseling programs. Today, she continues to work tirelessly to ensure that consumers are informed and involved in decisions that affect their health. by Kim Ribbink Over the [...]
By

Kim Ribbink

FEEDBACK